Identification of a caspase-2 isoform that behaves as an endogenous inhibitor of the caspase cascade

Cancer Research

Volumn 60, Issue 24, 2000, Pages 7039-7047

  Droin, Nathalie ^a,b   Beauchemin, Myriam ^a   Solary, Eric ^b   Bertrand, Richard ^a  

^a NOTRE DAME HOSPITAL   (Canada)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CAMPTOTHECIN; CASPASE 3; CASPASE INHIBITOR; CYSTEINE PROTEINASE; CYTOCHROME C; DNA FRAGMENT; ETOPOSIDE; FAS ANTIBODY; INHIBITOR OF APOPTOSIS PROTEIN; MESSENGER RNA; RECOMBINANT ENZYME; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ALPHA HELIX; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION;

AMINO ACID SEQUENCE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BASE SEQUENCE; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CASPASE 2; CASPASES; CELL DEATH; CELL LINE; CELL-FREE SYSTEM; CLONING, MOLECULAR; CYTOCHROME C GROUP; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ETOPOSIDE; HUMANS; KINETICS; LYMPHOMA; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; NUCLEIC ACID SYNTHESIS INHIBITORS; PRECIPITIN TESTS; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; TIME FACTORS; TISSUE DISTRIBUTION; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 0034671217     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
2. Cell death in development
3. The central effectors of cell death in the immune system
4. Apoptosis in the pathogenesis and treatment of disease
5. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: A cautionary note
6. Bc1-2 family proteins: Regulators of apoptosis and chemoresistance in hematologic malignancies
7. Activation and role of caspases in chemotherapy-induced apoptosis
8. Human ICE/CED-3 protease nomenclature
9. Proteases to die for
10. Caspase activation: The induced-proximity model
11. Caspase structure, proteolytic substrates, and function during apoptotic cell death
12. Prodomains-adaptors-oligomerization: The pursuit of caspase activation in apoptosis
13. Serial killers: Ordering caspase activation events in apoptosis
14. Apaf-1, a human protein homologous to C. Elegans Ced-4, participates in cytochrome c-dependent activation of caspase-3
15. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
16. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization
17. Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1
18. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain
19. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
20. Fadd/Mort1 is a common mediator of CD95 (Fas/Apo-1) and tumor necrosis factor receptor-induced apoptosis
21. Flice, a novel Fadd-homologous lce/Ced-3-like protease, is recruited to the CD95 (Fas/Apo-1) death-inducing signaling complex
22. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FDD-like domains
23. Involvement of Mach, a novel Mort1/Fadd-interacting protease, in Fas/Apo-1- and Tnf receptor-induced cell death
24. Nmr structure and mutagenesis of the Fas (Apo-1/Cd95) death domain
25. Nmr structure and mutagenesis of the Fadd (Mort1) death-effector domain
26. Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment
27. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death
28. Role of multiple cellular proteases in the execution of programmed cell death
29. Raidd is a new death adaptor molecule
30. Functional activation of Nedd2/Ich-1 (Caspase-2) is an early process in apoptosis
31. Caspase-2 (Nedd-2) processing and death of trophic factor-deprived PC12 cells and sympathetic neurons occur independently of caspase-3 (Cpp32)-like activity
32. Cradd, a novel human apoptotic adaptor molecule for caspase-2, and Fas/Tumor necrosis factor receptor-interacting protein Rip
33. The TNF receptor 1-associated protein TRADD signals cell death and NF-κ B activation
34. Targeted disruption of the mouse caspase 8 gene ablates cell death induction by the Tnf receptors, Fas/Apo1, and Dr3 and is lethal prenatally
35. Defects in regulation of apoptosis in caspase-2-deficient mice
36. Prodomain-dependent nuclear localization of the caspase-2 (Nedd2) precursor: A novel function for a caspase prodomain
37. Mitochondrial release of caspase-2 and -9 during the apoptotic process
38. Subcellular localization and CARD-dependent oligomerization of the death adaptor RAIDD
39. Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis
40. Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner
41. Cloning and expression of four novel isoforms of human interleukin-1 β converting enzyme with different apoptotic activities
42. Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family
43. Mch3, a novel human apoptotic cysteine protease highly related to Cpp32
44. Flice is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b
45. Molecular cloning and characterization of two novel pro-apoptotic isoforms of caspase-10
46. A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis
47. Identification of an endogenous dominant-negative short isoform of caspase-9 that can regulate apoptosis
48. Death-effector filaments: Novel cytoplasmic structures that recruit caspases and trigger apoptosis
49. A simple salting out procedure for extracting DNA from human nucleated cells
50. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c
51. Activation of caspases triggered by cytochrome C in vitro
52. Differential induction of secondary DNA fragmentation by topoisomerase Il inhibitors in human tumor cell lines with amplified c-myc expression
53. Characterization of Bax-σ, a novel cell death-inducing isoform of Bax
54. Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities
55. IAP family proteins: Suppressors of apoptosis
56. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis C-Iap2 is under Nf-K-B control
57. Nuclear factor (Nf)-K-B-regulated X-chromosome-linked 1ap gene expression protects endothelial cells from tumor necrosis factor α-induced apoptosis
58. Nf-K-B antiapoptosis: Induction of Traf1, and Traf2, and C-Iap1, and C-Iap2 to suppress caspase-8 activation
59. Control of apoptosis and mitotic spindle checkpoint by survivin
60. Inhibition of Fas death signals by FLIPs
61. Regulation of Ich-l pre-mRNA alternative splicing and apoptosis by mammalian splicing factors
62. Upregulation of Casp genes in human tumor cells undergoing etoposide-induced apoptosis
63. The prodomain of caspase-1 enhances Fas-mediated apoptosis through facilitation of caspase-8 activation
64. The death domain kinase RIP mediates the TNF-induced NF-κB signal
65. Synthetic activation of caspases: Artificial death switches
66. Conversion of procaspase-3 to an autoactivating caspase by fusion to the caspase-2 prodomain
67. Interleukin-1 β converting enzyme requires oligomerization for activity of processed forms in vivo
68. Functional characterization of the prodomain of interleukin-1-β-converting enzyme
69. Dimerization and autoprocessing of the Nedd2 (caspase-2) precursor requires both the prodomain and the carboxyl-terminal regions
70. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
71. Inhibition of death receptor signals by cellular Flip
72. Activation of caspase-1 in the nucleus requires nuclear translocation of pro-caspase-1 mediated by its prodomain
73. Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-κ B
74. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-κB